| 2024-11-01 | +7.4% | expansion | Seeking Alpha | Asahi Kasei, Honda sign shareholders agreement |
| 2022-08-04 | -6.9% | earnings | Seeking Alpha | Asahi Kasei; GAAP EPS of 21.50, revenue of 670.44B |
| 2025-05-09 | -5.5% | news | Seeking Alpha | Asahi Kasei reports FY results |
| 2023-08-03 | -5.3% | earnings | Seeking Alpha | Asahi Kasei reports FQ1 results |
| 2023-08-03 | -5.3% | news | Seeking Alpha | Asahi Kasei: Not A Bad Proposition |
| 2025-07-31 | +5.2% | earnings | Seeking Alpha | Asahi Kasei GAAP EPS of 14.52, revenue of 738.32B |
| 2025-07-31 | +5.2% | earnings | Seeking Alpha | Asahi Kasei Corporation (AHKSY) Q1 2025 Earnings Call Transcript |
| 2025-11-05 | +5.1% | news | Seeking Alpha | Asahi Kasei reports 1H results |
| 2026-04-20 | -5.0% | news | Zacks | Are Investors Undervaluing Asahi Kasei (AHKSY) Right Now? |
| 2026-04-20 | -5.0% | news | Business Wire | PeptiDream Announces the Initiation of Phase 1 Clinical Trial by Its Collaboration Partner |
| 2026-04-20 | -5.0% | M&A | Business Wire | Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical Strategy |
| 2026-04-20 | -5.0% | news | GlobeNewswire | Healthcare Filtration Markets 2025-2035 with Focus on Biologics Manufacturing Featuring Alfa Laval, Asahi Kasei, Cobetter, Corning, Merck, Pall, Parker Hannifin, Sartorius, Thermo Fisher Scientific |
| 2026-04-20 | -5.0% | news | Moomoo | Asahi Kasei: Aicuris Rev Expected to Reach $500 M by 2030 - Moomoo |
| 2026-04-20 | -5.0% | earnings | Stock Titan | Asahi Kasei adds 3 antiviral drugs, with FDA decision due in Q4 - Stock Titan |
| 2026-04-20 | -5.0% | M&A | Moomoo | Asahi Kasei Completes Acquisition Of Aicuris To Advance Its Global Pharmaceutical Strategy >3407.TO - Moomoo |
| 2026-04-20 | -5.0% | legal | Moomoo | Asahi Kasei: FDA Has Granted Priority Review for Pritelivir New Drug Application - Moomoo |
| 2026-04-20 | -5.0% | news | Moomoo | Asahi Kasei: Prescription Drug User Fee Act Target Date Is 4Q - Moomoo |
| 2026-04-20 | -5.0% | M&A | Moomoo | Asahi Kasei Expects Acquisition to Contribute Positively to Oper Income After Amortization of Goodwill and Other Intangible Assets From FY28 Onward - Moomoo |
| 2023-11-07 | +4.1% | news | Seeking Alpha | Asahi Kasei reports 1H results |
| 2025-04-10 | +3.5% | news | Quiver Quantitative | Cambria Endowment Style ETF Holdings - Quiver Quantitative |
| 2026-04-17 | -3.4% | news | Simply Wall St. | Honda Balances Fastport Micromobility Push With Ontario EV Delay |
| 2026-04-17 | -3.4% | news | Simply Wall St. | Is It Too Late To Consider Asahi Kasei (TSE:3407) After A 73% One-Year Surge? |
| 2025-08-19 | +3.3% | earnings | Seeking Alpha | Asahi Kasei Corporation 2025 Q1 - Results - Earnings Call Presentation |
| 2026-04-16 | +3.2% | analyst | Zacks | Asahi Kasei (AHKSY) Upgraded to Strong Buy: What Does It Mean for the Stock? |
| 2026-04-16 | +3.2% | news | Zacks | Best Momentum Stocks to Buy for April 16th |
| 2026-04-16 | +3.2% | news | Zacks | Best Value Stocks to Buy for April 16th |
| 2024-05-09 | -2.9% | news | Seeking Alpha | Asahi Kasei reports FY results |
| 2026-04-21 | -2.8% | M&A | Hospital Management | Asahi Kasei acquires German company Aicuris |
| 2022-04-19 | -2.4% | M&A | Seeking Alpha | Asahi Kasei Medical to acquire US-based biopharmaceutical CDMO Bionova Scientific |
| 2022-10-18 | -2.4% | legal | Seeking Alpha | Asahi Kasei Plastics Singapore secures approval to produce sustainable plastic |
| 2024-07-31 | -2.2% | earnings | Seeking Alpha | Asahi Kasei GAAP EPS of 24.59, revenue of 735.9B |
| 2025-04-17 | +1.9% | news | Seeking Alpha | Asahi Kasei: Materials Business Could Be Challenged By Macro |
| 2026-04-09 | -1.7% | news | Stock Titan | New 2 µm infrared laser could shrink sensors for CO2, CH4 detection - Stock Titan |
| 2023-10-18 | +1.6% | expansion | Seeking Alpha | Asahi Kasei launches 3D printing filaments in North America |
| 2024-05-28 | -1.5% | news | Seeking Alpha | Asahi Kasei To Pay A Fair Price For Calliditas Therapeutics |
| 2024-05-28 | -1.5% | news | Seeking Alpha | Asahi Kasei offers to buy Calliditas Therapeutics for $1.1B |
| 2026-02-25 | -1.1% | M&A | Stock Titan | New Asahi Kasei drug deal targets treatments for multiple autoimmune diseases - Stock Titan |
| 2025-10-17 | -1.1% | news | Moomoo | Industrial Micro Filter Market Analysis 2025-2031: Emerging Opportunities Across Semiconductor, Automotive & Pharma Industries | Valuates Reports - Moomoo |
| 2021-08-24 | -0.9% | executive | Seeking Alpha | Todd Glogovsky named Chief Operating Officer of Asahi Kasei unit |
| 2023-01-26 | +0.9% | news | Seeking Alpha | iVexSol closes $23.8M series A-3 financing by Bristol Myers Squibb, Charles River, Asahi Kasei |
| 2024-04-02 | +0.8% | earnings | Seeking Alpha | Asahi Kasei: Critical Care Should Improve In Margins And Revenues |
| 2024-11-04 | +0.2% | news | Seeking Alpha | Asahi Kasei: Still Looks Cheap 4 Years On |
| 2023-10-31 | +0.1% | news | Seeking Alpha | Asahi Kasei to expand coating capacity for lithium-ion battery separators |